FastPharming for Speed to Market

Tom Isett, Director, and Sylvain Marcel, Vice President, Protein Expression Sciences, iBio, Inc.


Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

iBio, Inc.

iBio Inc, founded in 2008, is a CDMO that develops and offers plant-made pharmaceutical product applications from the early stages of product selection through regulatory approval and commercial launch. iBio’s technology platform and facility capabilities are applicable to the development of monoclonal antibodies, therapeutic proteins, ADCs, vaccines, and combination medical devices, often providing significant time and value advantages over alternative development and manufacturing approaches. iBio’s Technology platform is a proprietary gene expression technology that causes non-transgenic plants to rapidly produce high levels of target proteins. The same team and facility that produces preclinical and clinical material is the same team producing the product for market launch, which contributes to the seamless scale-up process the iBio technology platform creates.